Horizon Pharma PLC (HZNP)

13.14
1.25 10.51
NASDAQ : Health Care
Prev Close 11.89
Open 11.85
Day Low/High 11.80 / 13.45
52 Wk Low/High 12.86 / 38.59
Volume 10.61M
Avg Volume 4.35M
Exchange NASDAQ
Shares Outstanding 163.35M
Market Cap 1.95B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

The Dow could close with its ninth day of records.

Biotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher

Biotech Movers: Second Quarter Results, Increased Outlook Send Horizon Pharma Shares Higher

Horizon Pharma, Mylan and Intellia Therapeutics were among the biotech stock movers in premarket trading on Aug. 7.

Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records

Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records

Stock futures are higher.

Horizon Pharma Stock Sees Short Interest Expand By 18.7%

The most recent short interest data has been released for the 07/14/2017 settlement date, which shows a 2,838,341 share increase in total short interest for Horizon Pharma plc , to 17,983,730, an increase of 18.74% since 06/30/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Horizon Pharma Plc Announces Four Poster Presentations On PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Capsules At Cystinosis Research Network 2017 Family Conference

Horizon Pharma Plc Announces Four Poster Presentations On PROCYSBI® (Cysteamine Bitartrate) Delayed-Release Capsules At Cystinosis Research Network 2017 Family Conference

-- In a New Study Comparing PROCYSBI and Immediate-Release Cysteamine, Those Treated with PROCYSBI Had a 26 Percent Reduction in Exhaled Dimethyl Sulphide, Which is Associated with Halitosis --

Horizon Pharma Plc Announces District Court Decision To Uphold VIMOVO® (naproxen/esomeprazole Magnesium) Patents

Patents Covering VIMOVO Infringed by Proposed Generics Developed by Dr. Reddy's Laboratories, Mylan, and Lupin

Epidemiologic Study Findings Show Over 400 Percent Increase In Gout Patient Hospitalizations Since 1993

Study Findings Underscore Burden of Gout on Patients and Healthcare System and Need for Improved Disease Management

5 Stocks Setting Up for Big Breakouts

5 Stocks Setting Up for Big Breakouts

Here's how to potentially rake in some fat profits off a number of hot breakout setups.

Short Interest In Horizon Pharma Falls 11.2%

The most recent short interest data has been released for the 05/15/2017 settlement date, which shows a 1,518,745 share decrease in total short interest for Horizon Pharma plc , to 12,055,991, a decrease of 11.19% since 04/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Horizon Pharma Plc Announces District Court Decision To Uphold PENNSAID® (diclofenac Sodium Topical Solution) 2% W/w Patent

Patent Covering PENNSAID® 2% Infringed by a Proposed Generic Developed by Actavis Laboratories UT, Inc.

Short Interest In Horizon Pharma Jumps 10%

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 1,239,832 share increase in total short interest for Horizon Pharma plc , to 13,574,736, an increase of 10.05% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Closing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard Hughes

Closing Bell: Volatility at Lowest Since 1993; Pershing Backs Howard Hughes

Volatility sank to its lowest level since 1993 to begin the new week as indexes held close to their flatlines.

Stocks Tread Water as Volatility Reaches Lowest Level in 24 Years

Stocks Tread Water as Volatility Reaches Lowest Level in 24 Years

Volatility sinks to its lowest level since Bill Clinton held the Oval Office, making for a listless and lethargic beginning to the new week.

Stocks Lower Again in 'Comfortably Numb' Trading, Volatility at 24-Year Low

Stocks Lower Again in 'Comfortably Numb' Trading, Volatility at 24-Year Low

Stocks are slightly lower again Monday afternoon as volatility hits its lowest level since the early 1990s.

Horizon Pharma is Now Oversold (HZNP)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Stocks Creep Lower in 'Comfortably Numb' Trading After French Election

Stocks Creep Lower in 'Comfortably Numb' Trading After French Election

Stocks creep lower on Monday after centrist Emmanuel Macron wins the French election, a result that was widely expected.

Biotech Movers: Horizon, OncoMed, Inovio

Biotech Movers: Horizon, OncoMed, Inovio

Horizon Pharma, OncoMed Pharmaceuticals and Inovio Pharmaceuticals were among the biotech stock movers in early trading on Monday.